In this review, the major physiological and metabolic actions of PACAP and VIP through their specific receptors are summarized, and the most recent advances in understanding the role of PACAP and VIP in the pathogenesis of metabolic diseases and obesity disorders are described. The gene discussed is ADCYAP1; the disease is Other metabolic disease.